DYN vs GRMN · $1.19B cap vs P/E 28, rev $6.30B
Dyne Therapeutics Inc (DYN) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
DYN does not have a complete income-statement cache yet.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
DYN currently screens at market cap $1.19B. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the DYN and GRMN stock pages for the full models.
Not investment advice.